Rusfertide Improves Responses, Meets Primary End Point of REVIVE Trial in Polycythemia Vera

Media coverage

• Title	Rusfertide Improves Responses, Meets Primary End Point of REVIVE Trial in Polycythemia Vera
  Media name/outlet	OncLive
  Country/Territory	United States
  Date	3/04/23
  URL	ct.moreover.com/?a=50420760371&p=1gw&v=1&x=YHK0SMzrQDV1DcPUSFLbCw
  Persons	Ronald Hoffman

• Title	Rusfertide Improves Responses, Meets Primary End Point of REVIVE Trial in Polycythemia Vera
  Media name/outlet	South Africa - Knowledia News
  Country/Territory	South Africa
  Date	3/04/23
  URL	ct.moreover.com/?a=50421153650&p=1gw&v=1&x=2VFdERp949E-8fMm0PkW1A
  Persons	Ronald Hoffman